AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30639273 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 30
Study 28459931 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate-day fasting (25% of energy needs on fast days; 125% of energy needs on feast days)
Number of subjects: 100
Study 28459931 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily calorie restriction (75% of energy needs every day)
Number of subjects: 100
Study 28459931 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 28459931 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate-day fasting
Number of subjects: 100
Study 28459931 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily calorie restriction
Number of subjects: 100
Study 25398725 — intervention group
Group type: EXPERIMENTAL
Intervention: Dr Kawashima's Brain Training (DKBT)
Number of subjects: 35
Study 25398725 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 35
Study 23826125 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 130
Study 23826125 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 130
Study 21716078 — intervention group
Group type: EXPERIMENTAL
Intervention: lamivudine-containing ART
Number of subjects: 106
Study 21716078 — intervention group
Group type: COMPARATOR
Intervention: non-HBV-active drugs
Number of subjects: 106
Study 21716078 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/HBV-coinfected participants
Number of subjects: 106
Study 21716078 — intervention group
Group type: COMPARATOR
Intervention: HIV monoinfected participants
Number of subjects: 106
Study 18287793 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc only (n = 11)
Number of subjects: 45
Study 18287793 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc + vitamin E (n = 12)
Number of subjects: 45
Study 18287793 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc + vitamins E + C (n = 14)
Number of subjects: 45
Study 18287793 — intervention group
Group type: COMPARATOR
Intervention: Zinc deficiency (in vitro experiment)
Number of subjects: 45
Study 17171204 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 mg of elemental iron weekly for 6 months (anemic children)
Number of subjects: 378
Study 17171204 — intervention group
Group type: COMPARATOR
Intervention: No intervention (non-anemic children)
Number of subjects: 378
Study 17171204 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 mg of elemental iron weekly for 6 months (both treated groups)
Number of subjects: 378
Study 14513188 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg diazepam
Number of subjects: 4
Study 14513188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 11094242 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic intrapartum amnioinfusion
Number of subjects: 1533
Study 11094242 — intervention group
Group type: COMPARATOR
Intervention: Control group (no amnioinfusion)
Number of subjects: 1533
Study 9142432 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimobendan
Number of subjects: 0
Study 9142432 — intervention group
Group type: COMPARATOR
Intervention: Milrinone and enoximone
Number of subjects: 0
Study 1582642 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytogenic preparation
Number of subjects: 90
Study 1582642 — intervention group
Group type: EXPERIMENTAL
Intervention: Ointment containing synthetic substances
Number of subjects: 90
Study 1582642 — intervention group
Group type: EXPERIMENTAL
Intervention: Ointment containing synthetic substances with corticoid
Number of subjects: 90
Study 3987543 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine (0.25, 0.75, 1.5 mg)
Number of subjects: 9
Study 3987543 — intervention group
Group type: COMPARATOR
Intervention: Verapamil (2.0, 4.0, 8.0 mg)
Number of subjects: 9
Study 3987543 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (15 mg) after felodipine and verapamil
Number of subjects: 9
Study 29284287 — intervention group
Group type: EXPERIMENTAL
Intervention: rAd-p53 therapy combined with radiotherapy and hyperthermia (p53 group)
Number of subjects: 71
Study 29284287 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy and hyperthermia alone (control group)
Number of subjects: 71
Study 27412888 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/day
Number of subjects: 62
Study 27412888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 25343963 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral loading dose of Vitamin D (500,000 IU) followed by an oral dose of 50,000 IU of Vitamin D monthly for 2 years
Number of subjects: 75
Study 25343963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 25343963 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral high‐dose vitamin D therapy
Number of subjects: 75
Study 23756453 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Directed Therapy (GDT)
Number of subjects: 42
Study 23756453 — intervention group
Group type: COMPARATOR
Intervention: Standard Fluid Therapy (Control)
Number of subjects: 42
Study 23756453 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthostatic Intolerance (OI)
Number of subjects: 42
Study 20806388 — intervention group
Group type: EXPERIMENTAL
Intervention: GreenLight HPS laser (532 nm, 120 W)
Number of subjects: 139
Study 20806388 — intervention group
Group type: COMPARATOR
Intervention: Diode laser (980 nm, 200 W)
Number of subjects: 139
Study 18162183 — intervention group
Group type: EXPERIMENTAL
Intervention: Left‐on unilateral STN DBS
Number of subjects: 49
Study 18162183 — intervention group
Group type: EXPERIMENTAL
Intervention: Right‐on unilateral STN DBS
Number of subjects: 49
Study 18162183 — intervention group
Group type: COMPARATOR
Intervention: Bilateral STN DBS
Number of subjects: 49
Study 15982505 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg co-administered with simvastatin 10 mg or 20 mg
Number of subjects: 372
Study 15982505 — intervention group
Group type: COMPARATOR
Intervention: Placebo co-administered with simvastatin 10 mg or 20 mg
Number of subjects: 372
Study 12626793 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention (8-week adjunctive psychological intervention)
Number of subjects: 53
Study 12626793 — intervention group
Group type: COMPARATOR
Intervention: Routine medical management (Control group)
Number of subjects: 53
Study 11097197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine (80 mg/70 kg p.o.)
Number of subjects: 35
Study 11097197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 11097197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine and Placebo (both)
Number of subjects: 35
Study 9206191 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 150 mg in separated doses followed by PG05 1 mg vaginally
Number of subjects: 4500
Study 9206191 — intervention group
Group type: COMPARATOR
Intervention: Mifepristone 200 mg in single dose followed by PG05 1 mg vaginally
Number of subjects: 4500
Study 9206191 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 4500
Study 1392491 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 60
Study 1392491 — intervention group
Group type: COMPARATOR
Intervention: Western Medicine (WM)
Number of subjects: 60
Study 3919522 — intervention group
Group type: EXPERIMENTAL
Intervention: High phosphate group (60-80 mmol phosphate/day)
Number of subjects: 30
Study 3919522 — intervention group
Group type: COMPARATOR
Intervention: Low phosphate group (7.5 mmol phosphate from fat emulsion)
Number of subjects: 30
Study 3919522 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition programme
Number of subjects: 30
Study 3919522 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate supplementation (80 mmol phosphate/day)
Number of subjects: 30
Study 29125679 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Tranexamic Acid (TXA) 500 mg in 5 mL
Number of subjects: 124
Study 29125679 — intervention group
Group type: COMPARATOR
Intervention: Anterior Nasal Packing (ANP)
Number of subjects: 124
Study 28471579 — intervention group
Group type: EXPERIMENTAL
Intervention: Spa therapy plus pharmacological treatment for 21 days
Number of subjects: 0
Study 28471579 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological treatment alone
Number of subjects: 0
Study 25109581 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 10
Study 25109581 — intervention group
Group type: COMPARATOR
Intervention: Conventional rotating handpiece
Number of subjects: 10
Study 22533654 — intervention group
Group type: EXPERIMENTAL
Intervention: AZL‐M 40 mg and CLD 25 mg
Number of subjects: 1714
Study 22533654 — intervention group
Group type: COMPARATOR
Intervention: AZL‐M 80 mg
Number of subjects: 1714
Study 22533654 — intervention group
Group type: COMPARATOR
Intervention: CLD 25 mg
Number of subjects: 1714
Study 20667790 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis within 3-4.5 hours after stroke onset
Number of subjects: 23942
Study 20667790 — intervention group
Group type: COMPARATOR
Intervention: Thrombolysis within 3 hours
Number of subjects: 23942
Study 17851130 — intervention group
Group type: EXPERIMENTAL
Intervention: SLN resection followed by conventional ALND
Number of subjects: 5611
Study 17851130 — intervention group
Group type: COMPARATOR
Intervention: SLN resection alone
Number of subjects: 5611
Study 16109117 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex 500 mg/day
Number of subjects: 132
Study 16109117 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex 1000 mg/day
Number of subjects: 132
Study 16109117 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex 1500 mg/day
Number of subjects: 132
Study 16109117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 12145720 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (750 mg once per day)
Number of subjects: 399
Study 12145720 — intervention group
Group type: COMPARATOR
Intervention: Ticarcillin-clavulanate (3.1 g iv every 4-6 hours) followed by amoxicillin-clavulanate (875 mg orally every 12 hours)
Number of subjects: 399
Study 11026121 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone maintenance treatment (MMP) with adjunctive manual-guided psychosocial group interventions
Number of subjects: 302
Study 11026121 — intervention group
Group type: COMPARATOR
Intervention: Methadone maintenance treatment (MMP)
Number of subjects: 302
Study 9109829 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin carrot (2 cm length, 2 cm width, 0.5 cm thickness)
Number of subjects: 9
Study 9109829 — intervention group
Group type: COMPARATOR
Intervention: Cheese (2 cm length, 2 cm width, 0.5 cm thickness)
Number of subjects: 9
Study 9109829 — intervention group
Group type: EXPERIMENTAL
Intervention: Thickest sample (1.5 cm thickness)
Number of subjects: 9
Study 9109829 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrot (thin)
Number of subjects: 9
Study 9109829 — intervention group
Group type: COMPARATOR
Intervention: Cheese (thin)
Number of subjects: 9
Study 9109829 — intervention group
Group type: EXPERIMENTAL
Intervention: Thickest sample
Number of subjects: 9
Study 8477058 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen S1 (cranial irradiation 18 Gy and intrathecal chemotherapy starting at 5 weeks)
Number of subjects: 207
Study 8477058 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen S2 (cranial irradiation and intrathecal chemotherapy starting at 24 weeks)
Number of subjects: 207
Study 8477058 — intervention group
Group type: EXPERIMENTAL
Intervention: Total population
Number of subjects: 207
Study 3762903 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0
Study 3762903 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense exercise
Number of subjects: 0
Study 3762903 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) and intense exercise (combined)
Number of subjects: 0
Study 31313062 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 279
Study 31313062 — intervention group
Group type: COMPARATOR
Intervention: Combination of CBT and sertraline
Number of subjects: 279
Study 29523651 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (1 mA, 20 minutes)
Number of subjects: 58
Study 29523651 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 58
Study 26612882 — intervention group
Group type: EXPERIMENTAL
Intervention: SafeR
Number of subjects: 646
Study 26612882 — intervention group
Group type: COMPARATOR
Intervention: DDD
Number of subjects: 646
Study 24777475 — intervention group
Group type: EXPERIMENTAL
Intervention: Female bully with female victim
Number of subjects: 437
Study 24777475 — intervention group
Group type: EXPERIMENTAL
Intervention: Male bully with female victim
Number of subjects: 437
Study 24777475 — intervention group
Group type: EXPERIMENTAL
Intervention: Female bully with male victim
Number of subjects: 437
Study 24777475 — intervention group
Group type: EXPERIMENTAL
Intervention: Male bully with male victim
Number of subjects: 437
Study 23192720 — intervention group
Group type: EXPERIMENTAL
Intervention: Compelled body weight shift (CBWS) therapy combined with physical therapy
Number of subjects: 18
Study 23192720 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (Control)
Number of subjects: 18
Study 20384426 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.84 g/kg for men, 0.76 g/kg for women)
Number of subjects: 130
Study 20384426 — intervention group
Group type: COMPARATOR
Intervention: Active placebo
Number of subjects: 130
Study 18840807 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance exercise (n=36)
Number of subjects: 66
Study 18840807 — intervention group
Group type: COMPARATOR
Intervention: Health education control program (n=30)
Number of subjects: 66
Study 15818329 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal photopheresis (ECP)
Number of subjects: 4
Study 15818329 — intervention group
Group type: COMPARATOR
Intervention: Conventional immunosuppressive treatment
Number of subjects: 4
Study 12612717 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg/day
Number of subjects: 57
Study 12612717 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg/day
Number of subjects: 57
Study 10342550 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral albuterol
Number of subjects: 59
Study 10342550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 8546441 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (rhGH)
Number of subjects: 34
Study 8546441 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 34
Study 1790086 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 60
Study 1790086 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 60
Study 31159537 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX)
Number of subjects: 54
Study 31159537 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (BUP)
Number of subjects: 54
Study 28602413 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Therapy and Radiation Therapy (HT-RT)
Number of subjects: 722
Study 28602413 — intervention group
Group type: COMPARATOR
Intervention: Hormone Therapy (HT)
Number of subjects: 722
Study 25542519 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical artificial tears
Number of subjects: 60
Study 25542519 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate 0.5%
Number of subjects: 60
Study 25542519 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate 0.5%/tobramycin 0.3%
Number of subjects: 60
Study 25542519 — intervention group
Group type: COMPARATOR
Intervention: Control group (age‐matched)
Number of subjects: 60
Study 23421327 — intervention group
Group type: EXPERIMENTAL
Intervention: Wash product (n = 159)
Number of subjects: 307
Study 23421327 — intervention group
Group type: COMPARATOR
Intervention: Water alone (n = 148)
Number of subjects: 307
Study 20827284 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 50
Study 20827284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 19820284 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin (5/10 mg)
Number of subjects: 739
Study 19820284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 739
Study 17380986 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehension program integrated with social studies instruction
Number of subjects: 0
Study 17380986 — intervention group
Group type: COMPARATOR
Intervention: Content-only program focusing on social studies
Number of subjects: 0
Study 17380986 — intervention group
Group type: COMPARATOR
Intervention: No-instruction control
Number of subjects: 0
Study 15118484 — intervention group
Group type: COMPARATOR
Intervention: Abnormal Involuntary Movement Scale (AIMS)
Number of subjects: 100
Study 15118484 — intervention group
Group type: COMPARATOR
Intervention: Dyskinesia Identification Scale, Condensed User Version (DISCUS)
Number of subjects: 100
Study 15118484 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental assessment
Number of subjects: 100
Study 15118484 — intervention group
Group type: COMPARATOR
Intervention: Mini‐Mental Status Examination
Number of subjects: 100
Study 11447543 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilute epinephrine irrigation (0.33 mg/L)
Number of subjects: 54
Study 11447543 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (plain saline irrigation)
Number of subjects: 54
Study 9497191 — intervention group
Group type: EXPERIMENTAL
Intervention: MM+MNF
Number of subjects: 25
Study 9497191 — intervention group
Group type: EXPERIMENTAL
Intervention: MM+CaGP
Number of subjects: 25
Study 9497191 — intervention group
Group type: COMPARATOR
Intervention: PTF
Number of subjects: 25
Study 8056798 — intervention group
Group type: EXPERIMENTAL
Intervention: RD heparin administered twice daily (50 anti-factor-Xa units/kg, subcutaneously, twice daily)
Number of subjects: 969
Study 8056798 — intervention group
Group type: EXPERIMENTAL
Intervention: RD heparin administered once daily (90 anti-factor-Xa units/kg, subcutaneously, once daily)
Number of subjects: 969
Study 8056798 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (5 mg orally preoperatively, adjusted daily)
Number of subjects: 969
Study 3052556 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 60 mg
Number of subjects: 75
Study 3052556 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 30 mg
Number of subjects: 75
Study 3052556 — intervention group
Group type: COMPARATOR
Intervention: Dihydrocodeine 30 mg
Number of subjects: 75
Study 31356514 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐second/4‐minute interval training protocol
Number of subjects: 8
Study 31356514 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐minute/1‐minute interval training protocol
Number of subjects: 8
Study 31356514 — intervention group
Group type: EXPERIMENTAL
Intervention: 4‐minute/3‐minute interval training protocol
Number of subjects: 8
Study 31356514 — intervention group
Group type: COMPARATOR
Intervention: 45‐minute continuous exercise session
Number of subjects: 8
Study 31664298 — intervention group
Group type: EXPERIMENTAL
Intervention: R3 (Halitosil Zn) mouth rinse
Number of subjects: 90
Study 31664298 — intervention group
Group type: EXPERIMENTAL
Intervention: R2 (Colgate plax) mouth rinse
Number of subjects: 90
Study 31664298 — intervention group
Group type: EXPERIMENTAL
Intervention: R7 (Oxyfresh power mouth rinse lemon‐mint)
Number of subjects: 90
Study 31664298 — intervention group
Group type: EXPERIMENTAL
Intervention: R8 (Signal expert protection)
Number of subjects: 90
Study 31664298 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth rinses containing ZnCl2 without alcohol
Number of subjects: 90
Study 31664298 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth rinses containing ethyl and other alcohols
Number of subjects: 90
Study 31664298 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshness effect
Number of subjects: 90
Study 29354975 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at distal acupoints (Guangming GB 37, Diwuhui GB 42)
Number of subjects: 40
Study 29354975 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture at local acupoints (Cuanzhu BL 2, Tongziliao GB 1, Taiyang EX-HN 5)
Number of subjects: 40
Study 25906557 — intervention group
Group type: EXPERIMENTAL
Intervention: Opposing needling technique
Number of subjects: 40
Study 25906557 — intervention group
Group type: COMPARATOR
Intervention: Affected side needling technique
Number of subjects: 40
Study 24138325 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision making programme
Number of subjects: 154
Study 24138325 — intervention group
Group type: COMPARATOR
Intervention: Control-intervention targeting nutrition, sports, and stress coping
Number of subjects: 154
Study 21388622 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ) supplement (300 mg/day)
Number of subjects: 28
Study 21388622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 19016091 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-assisted computerized cognitive behavioural treatment (CaCCBT)
Number of subjects: 98
Study 19016091 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided computerized CBT (CCBT)
Number of subjects: 98
Study 19016091 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 98
Study 16140281 — intervention group
Group type: EXPERIMENTAL
Intervention: Iomazenil
Number of subjects: 23
Study 16140281 — intervention group
Group type: EXPERIMENTAL
Intervention: m-CPP
Number of subjects: 23
Study 16140281 — intervention group
Group type: EXPERIMENTAL
Intervention: Iomazenil and m-CPP
Number of subjects: 23
Study 16140281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 12653682 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MS) subjects
Number of subjects: 35
Study 12653682 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma campesterol:cholesterol ratio
Number of subjects: 35
Study 10911512 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaleplon 10 mg alone
Number of subjects: 17
Study 10911512 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg alone
Number of subjects: 17